Expression of Myeloid Antigen in Neoplastic Plasma Cells Is Related to Adverse Prognosis in Patients with Multiple Myeloma

by Hyoeun Shim, Joo Hee Ha, Hyewon Lee, Ji Yeon Sohn, Hyun Ju Kim, Hyeon-Seok Eom, Sun-Young Kong
Published 2014-01-01

Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOP

by Min Kyeong Kim, Kyong-Ah Yoon, Eun Young Park, Jungnam Joo, Eun Young Lee, Hyeon-Seok Eom, Sun-Young Kong
Published 2016-12-01

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma

by Jongheon Jung, Hyewon Lee, Ja Yoon Heo, Myung Hee Chang, Eunyoung Lee, Weon Seo Park, Ju-Hyun Park, Hyeon-Seok Eom
Published 2021-01-01

Elevated Red Blood Cell Distribution Width as a Simple Prognostic Factor in Patients with Symptomatic Multiple Myeloma

by Hyewon Lee, Sun-Young Kong, Ji Yeon Sohn, Hyoeun Shim, Hye Sun Youn, Sangeun Lee, Hyun Ju Kim, Hyeon-Seok Eom
Published 2014-01-01

Chromothripsis in Treatment Resistance in Multiple Myeloma

by Kyoung Joo Lee, Ki Hong Lee, Kyong-Ah Yoon, Ji Yeon Sohn, Eunyoung Lee, Hyewon Lee, Hyeon-Seok Eom, Sun-Young Kong
Published 2017-09-01

Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor

by Chungyong Han, Beom K. Choi, Seon-Hee Kim, Su-Jung Sim, Seongeun Han, Bomi Park, Yohei Tsuchiya, Masaki Takahashi, Young H. Kim, Hyeon-Seok Eom, Tetsuya Kitaguchi, Hiroshi Ueda, Byoung S. Kwon
Published 2020-06-01

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

by Ho-Young Yhim, Dok Hyun Yoon, Seok Jin Kim, Deok-Hwan Yang, Hyeon-Seok Eom, Kyoung Ha Kim, Yong Park, Jin Seok Kim, Hyo Jung Kim, Cheolwon Suh, Won Seog Kim, Jae-Yong Kwak
Published 2020-08-01

Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study

by Huiqiang Huang, Jun Zhu, Ming Yao, Tae Min Kim, Dok Hyun Yoon, Seok-Goo Cho, Hyeon Seok Eom, Soon Thye Lim, Su-peng Yeh, Yuqin Song, Yok Lam Kwong, Jin Seok Kim, Jie Jin, Yuankai Shi, HyeJin Kim, Min Qing, Tianyuan Zhou, Grace Gao, Zongqi Dong, Ming Qi, Won Seog Kim
Published 2021-02-01

Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea

by Ho Sup Lee, Kihyun Kim, Dok Hyun Yoon, Jin Seok Kim, Soo-Mee Bang, Jeong-Ok Lee, Hyeon Seok Eom, Hyewon Lee, Inho Kim, Won Sik Lee, Sung Hwa Bae, Se Hyung Kim, Mark Hong Lee, Young Rok Do, Jae Hoon Lee, Junshik Hong, Ho-Jin Shin, Ji Hyun Lee, Yeung-Chul Mun, Chang-Ki Min
Published 2014-01-01

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

by Jun Ho Yi, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Myung Hee Chang, Deok Hwan Yang, Jae‐Cheol Jo, Shin Young Hyun, Hyeon‐Seok Eom, Jeong‐Ok Lee, Ji Hyun Kwon, Sang Hoon Han, Seung‐Shin Lee, Jae‐Yong Kwak, Se Hyung Kim, Dae Sik Kim, Ji Hyun Lee, Sung Yong Oh, Hun Mo Ryoo, Hyo Jung Kim, Won Seog Kim
Published 2021-03-01